186 related articles for article (PubMed ID: 33466237)
1. Risk of Cancer Following the Use of N-Nitrosodimethylamine (NDMA) Contaminated Ranitidine Products: A Nationwide Cohort Study in South Korea.
Yoon HJ; Kim JH; Seo GH; Park H
J Clin Med; 2021 Jan; 10(1):. PubMed ID: 33466237
[TBL] [Abstract][Full Text] [Related]
2. Pharmacoepidemiological Research on N-Nitrosodimethylamine-Contaminated Ranitidine Use and Long-Term Cancer Risk: A Population-Based Longitudinal Cohort Study.
Wang CH; Chen II; Chen CH; Tseng YT
Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231768
[TBL] [Abstract][Full Text] [Related]
3. Association between ranitidine use with potential NDMA impurities and risk of cancer in Korea.
Joung KI; Hwang JE; Oh IS; Cho SI; Shin JY
Sci Rep; 2022 Dec; 12(1):22396. PubMed ID: 36575247
[TBL] [Abstract][Full Text] [Related]
4. Ranitidine Use and Incident Cancer in a Multinational Cohort.
You SC; Seo SI; Falconer T; Yanover C; Duarte-Salles T; Seager S; Posada JD; Shah NH; Nguyen PA; Kim Y; Hsu JC; Van Zandt M; Hsu MH; Lee HL; Ko H; Shin WG; Pratt N; Park RW; Reich CG; Suchard MA; Hripcsak G; Park CH; Prieto-Alhambra D
JAMA Netw Open; 2023 Sep; 6(9):e2333495. PubMed ID: 37725377
[TBL] [Abstract][Full Text] [Related]
5. Use of N-nitrosodimethylamine (NDMA) contaminated valsartan products and risk of cancer: Danish nationwide cohort study.
Pottegård A; Kristensen KB; Ernst MT; Johansen NB; Quartarolo P; Hallas J
BMJ; 2018 Sep; 362():k3851. PubMed ID: 30209057
[TBL] [Abstract][Full Text] [Related]
6. Oral intake of ranitidine increases urinary excretion of N-nitrosodimethylamine.
Zeng T; Mitch WA
Carcinogenesis; 2016 Jun; 37(6):625-634. PubMed ID: 26992900
[TBL] [Abstract][Full Text] [Related]
7. N-nitrosodimethylamine (NDMA) contamination of ranitidine products: A review of recent findings.
Aldawsari FS; Alshehry YM; Alghamdi TS
J Food Drug Anal; 2021 Mar; 29(1):39-45. PubMed ID: 35696227
[TBL] [Abstract][Full Text] [Related]
8. N-Nitrosodimethylamine (NDMA) Formation from Ranitidine Impurities: Possible Root Causes of the Presence of NDMA in Ranitidine Hydrochloride.
Yokoo H; Yamamoto E; Masada S; Uchiyama N; Tsuji G; Hakamatsuka T; Demizu Y; Izutsu KI; Goda Y
Chem Pharm Bull (Tokyo); 2021; 69(9):872-876. PubMed ID: 34470951
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Analysis of N-Nitrosodimethylamine (NDMA) Formation From Ranitidine Under Simulated Gastrointestinal Conditions.
Gao Z; Karfunkle M; Ye W; Marzan TA; Yang J; Lex T; Sommers C; Rodriguez JD; Han X; Florian J; Strauss DG; Keire DA
JAMA Netw Open; 2021 Jun; 4(6):e2118253. PubMed ID: 34181009
[TBL] [Abstract][Full Text] [Related]
10. No association between chronic use of ranitidine, compared with omeprazole or famotidine, and gastrointestinal malignancies.
Kim YD; Wang J; Shibli F; Poels KE; Ganocy SJ; Fass R
Aliment Pharmacol Ther; 2021 Sep; 54(5):606-615. PubMed ID: 34251045
[TBL] [Abstract][Full Text] [Related]
11. Effect of Oral Ranitidine on Urinary Excretion of N-Nitrosodimethylamine (NDMA): A Randomized Clinical Trial.
Florian J; Matta MK; DePalma R; Gershuny V; Patel V; Hsiao CH; Zusterzeel R; Rouse R; Prentice K; Nalepinski CG; Kim I; Yi S; Zhao L; Yoon M; Selaya S; Keire D; Korvick J; Strauss DG
JAMA; 2021 Jul; 326(3):240-249. PubMed ID: 34180947
[TBL] [Abstract][Full Text] [Related]
12. Characterization of N-nitrosodimethylamine formation from the ozonation of ranitidine.
Lv J; Wang L; Li Y
J Environ Sci (China); 2017 Aug; 58():116-126. PubMed ID: 28774600
[TBL] [Abstract][Full Text] [Related]
13. Determination of
Liu J; Zhao Z; Yang X; Jin Y; Liu X; Wang C; Zhang Z
Iran J Pharm Res; 2021; 20(4):255-264. PubMed ID: 35194444
[TBL] [Abstract][Full Text] [Related]
14. A Bioanalytical Method for Quantification of N-nitrosodimethylamine (NDMA) in Human Plasma and Urine with Different Meals and following Administration of Ranitidine.
De Palma R; Patel V; Florian J; Keire D; Selaya D; Strauss DG; Rouse R; Matta MK
J Pharm Sci; 2023 May; 112(5):1315-1323. PubMed ID: 36736776
[TBL] [Abstract][Full Text] [Related]
15. Drug Utilisation Patterns of Alternatives to Ranitidine-Containing Medicines in Patients Treated with Ranitidine: A Network Analysis of Data from Six European National Databases.
Arinze JT; de Ridder MAJ; Vojinovic D; van Ballegooijen H; Markov E; Duarte-Salles T; Rijnbeek P; Verhamme KMC
Drug Saf; 2023 Dec; 46(12):1353-1362. PubMed ID: 37907775
[TBL] [Abstract][Full Text] [Related]
16. Reduction of N-nitrosodimethylamine formation from ranitidine by ozonation preceding chloramination: influencing factors and mechanisms.
Zou R; Liao X; Zhao L; Yuan B
Environ Sci Pollut Res Int; 2018 May; 25(14):13489-13498. PubMed ID: 29492817
[TBL] [Abstract][Full Text] [Related]
17. Ranitidine: A Proposed Mechanistic Rationale for NDMA Formation and a Potential Control Strategy.
Harmon P
J Pharm Sci; 2023 May; 112(5):1220-1224. PubMed ID: 36384193
[TBL] [Abstract][Full Text] [Related]
18. Effect of Ranitidine Intake on the Risk of Gastric Cancer Development.
Kim S; Lee S; Hong J; Ko I; Kim JY; Kim DK
Healthcare (Basel); 2021 Aug; 9(8):. PubMed ID: 34442208
[TBL] [Abstract][Full Text] [Related]
19. Temperature-Dependent Formation of N-Nitrosodimethylamine during the Storage of Ranitidine Reagent Powders and Tablets.
Abe Y; Yamamoto E; Yoshida H; Usui A; Tomita N; Kanno H; Masada S; Yokoo H; Tsuji G; Uchiyama N; Hakamatsuka T; Demizu Y; Izutsu KI; Goda Y; Okuda H
Chem Pharm Bull (Tokyo); 2020 Oct; 68(10):1008-1012. PubMed ID: 32779580
[TBL] [Abstract][Full Text] [Related]
20. The Association between Ranitidine Use and Gastrointestinal Cancers.
McGwin G
Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33374592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
